The impact of pulmonary artery to ascending aorta diameter ratio progression on the prognosis of NSCLC patients treated with immune checkpoint inhibitors

The impact of pulmonary artery to ascending aorta diameter ratio progression on the prognosis of NSCLC patients treated with immune checkpoint inhibitors

BackgroundImmunotherapy, represented by immune checkpoint inhibitors (ICIs), is a major breakthrough in cancer treatment. Studies have reported that the use of ICIs is associated with an increase in the pulmonary artery to ascending aorta diameter (PAD/AoD) ratio. However, the impact of PAD/AoD rati...

Full description

Bibliographic Details
Main Authors: Bingxin Gong, Yi Li, Yusheng Guo, Jing Wang, Weiwei Liu, Guofeng Zhou, Jiyu Song, Feng Pan, Lian Yang, Bo Liang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Immunology
Subjects:
pulmonary artery diameter
ascending aorta diameter
immune checkpoint inhibitors
non-small cell lung cancer
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1302233/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1302233/full

Similar Items